Active-ingredient Dossier
Tobramycin
Active-ingredient Dossier for Tobramycin (aminoglycoside antibiotic). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: TOBI
- Brand: TOBRA-DAY
- Brand: TOBRAMYCIN
- Brand: TOBRAMYCIN
- Brand: TOBRAMYCIN
- Brand: TOBREX
- Therapeutic area: Infectious Disease
- Therapeutic area: Respiratory
- Therapeutic area: Ophthalmology
What is
Tobramycin Tobramycin is an aminoglycoside antibiotic.
Australian brands containing
Tobramycin — TOBI — TOBRAMYCIN — TOBREX — NEBCIN
Therapeutic areas
Tobramycin is registered in infectious disease, with seven brands containing the ingredient on the ARTG.
Sponsor landscape
Tobramycin is marketed by seven sponsors: Aspen Pharmacare, Viatris, Sun Pharma, Alphapharm, Arrotex Pharmaceuticals, and Juno Pharmaceuticals.
PBS and regulatory activity
Two brands containing tobramycin have PBS-listed items, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome on record is from 1 July 2017, and the latest AusPAR is from 27 February 2012.